| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 11/02/2004 | US6811573 Dyes for keratin fibres containing 1,3-diamino-4-heteroarylbenzene derivatives and novel 1,3-diamino-4-heteroarylbenzene derivatives |
| 10/28/2004 | WO2004092146A2 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes |
| 10/28/2004 | WO2004092131A1 Indole derivatives as ppar modulators |
| 10/28/2004 | WO2004092119A2 Method for producing alpha-methylated cysteine and serine derivatives |
| 10/28/2004 | WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | WO2004092115A2 Hydroxamates as therapeutic agents |
| 10/28/2004 | WO2004091613A2 Substituted phenyl acetamides and their use as protease inhibitors |
| 10/28/2004 | WO2004076386A3 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| 10/28/2004 | WO2004038374A3 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 10/28/2004 | WO2003018515A3 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 10/28/2004 | US20040214999 Novel compounds for chemiluminescense procedures |
| 10/28/2004 | US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis |
| 10/28/2004 | US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal |
| 10/28/2004 | US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same |
| 10/28/2004 | US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 10/28/2004 | US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug |
| 10/28/2004 | US20040214107 optical and electro-optical apparatus comprising recording layer consists of organic pigments and stabilizer agents, and reflection layers formed on light transmitting substrates; sensitivity for red light |
| 10/28/2004 | US20040213736 Introducing into the subject a ligand capable of labelling aggregated paired helical filament (PHF) tau protein, determining the presence and\or amount of ligand bound to extracellular aggregated PHF tau in the medial temporal lobe of the brain, correlating the result of the determination |
| 10/28/2004 | CA2522080A1 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes |
| 10/28/2004 | CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/27/2004 | EP1471064A1 Coumarin derivatives, process for their production and use thereof |
| 10/27/2004 | EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 10/27/2004 | EP1470752A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541097A 2-amino-4, 5-trisubstituted thiazolyl derivatives |
| 10/27/2004 | CN1539816A IL-8 receptor antagonist |
| 10/26/2004 | US6809203 Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analogs thereof |
| 10/26/2004 | US6809110 Noninsulin dependent diabetes; such as 2-ethoxy-3-(4-(2-(5-methyl-2-phenyl-thiazol-4-yl)-ethoxy)-benzo(b)thiophen-7-yl)-propionic acid |
| 10/26/2004 | US6809107 Neurodegenerative diseases |
| 10/26/2004 | US6809101 Compounds having anti-hepatitis C virus effect |
| 10/26/2004 | US6809088 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 10/26/2004 | CA2418634C Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 10/21/2004 | WO2004089942A2 Benzimidazolidinone derivatives as muscarinic agents |
| 10/21/2004 | WO2004089927A1 Novel methods for the treatment of inflammatory diseases |
| 10/21/2004 | WO2004089922A2 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 10/21/2004 | WO2004089918A1 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 10/21/2004 | WO2004089885A1 Novel compounds |
| 10/21/2004 | WO2004089878A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE α-AMINONITRILE COMPOUND |
| 10/21/2004 | WO2004089377A1 Calcium channel blockers comprising two benzhydril moieties |
| 10/21/2004 | WO2004089356A2 Targeted bone marrow protection agents |
| 10/21/2004 | WO2004089276A2 Thiazolidinedione compounds with hypoglycemic properties |
| 10/21/2004 | WO2004047760A3 Novel chemical compounds |
| 10/21/2004 | US20040210063 Novel 2,4-diaminothiazole derivatives |
| 10/21/2004 | US20040210062 Process of production of n-alkyl-2-benzthiazolysulfeneimides, device for their production and method of their purification |
| 10/21/2004 | US20040210059 Carboxylic acids, optionally in the form of amino acids, react with chloroformates to yield intermediates, which react with amines |
| 10/21/2004 | US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents |
| 10/21/2004 | US20040209926 asymmetrically-substituted xylylenediamines, e.g., N-(3-aminopropyl)-xylylenediamine; cancer, mucositis, asthma, inflammation, autoimmune disease, psoriasis, restentosis, rheumatoid arthritis, scleroderma, lupus, diabetes, tissue transplantation, osteoporosis, hyperparathyroidism, peptic ulcers, glaucoma |
| 10/21/2004 | US20040209925 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 10/21/2004 | US20040209891 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV |
| 10/21/2004 | US20040209872 Calcium channel blockers comprising two benzhydril moieties |
| 10/21/2004 | CA2521875A1 Calcium channel blockers comprising two benzhydril moieties |
| 10/21/2004 | CA2521830A1 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 10/21/2004 | CA2521606A1 Novel methods for the treatment of inflammatory diseases |
| 10/20/2004 | EP1468990A1 Piperazine derivative |
| 10/20/2004 | EP1468331A2 Polymeric material, containing a latent acid |
| 10/20/2004 | EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 10/20/2004 | EP1467981A1 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2 |
| 10/20/2004 | EP1467980A1 Method for producing halogenated 2-(3-butenylsulfanyl)-1,3-thiazoles |
| 10/20/2004 | EP1443045A9 Carbanilide used as pesticide |
| 10/20/2004 | EP1282611B1 Substituted phenylacetamides and their use as glucokinase activators |
| 10/20/2004 | EP1155076B1 In situ preparation of a bis-(benzothiazolesulfen)amide in a polymeric matrix |
| 10/20/2004 | CN1538955A Pyrrolidine derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1171872C Compounds for modulation of PPAP gamma activity |
| 10/20/2004 | CN1171863C Carbamate derivatives and agricultural/horticulatrual bactericides |
| 10/19/2004 | US6806378 Catalyst system and a process for the preparation of a nonracemic chiral alcohol by hydrogenation of a ketone using the catalyst system, wherein the catalyst system comprises ruthenium, a nonracemic chiral diphosphine ligand, an |
| 10/19/2004 | US6806369 N-formyl-n-hydroxy-2-(5-isoquinolinoxy)ethylamine anti-bacterial compounds |
| 10/19/2004 | US6806365 N-alkanoylphenylalamine derivatives |
| 10/19/2004 | CA2343336C Processes for preparing intermediates to nizatidine |
| 10/14/2004 | WO2004071448A3 Substituted azole derivatives as inhibitors of protein tyrosine phosphatases |
| 10/14/2004 | WO2004056727A3 Process of making chalcone derivatives |
| 10/14/2004 | WO2004000785A3 Phenyloxyalkanonic acid derivatives as hppar activators |
| 10/14/2004 | US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 10/14/2004 | US20040204477 For use as antiproliferative agents |
| 10/14/2004 | US20040204412 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer |
| 10/14/2004 | US20040204405 Thiazines and thiazoles as agents for protecting materials |
| 10/14/2004 | US20040204344 bifunctional molecules containing at least one metal-chelating group associated with at least one amyloid-binding group e.g a benzothiazole derivative; for treating pathophysiological condition selected from Alzheimer's disease, Down's syndrome, Lewy body dementia, Guam Parkinson-Dementia, head trauma |
| 10/13/2004 | EP1466912A1 2-acylaminothiazole derivative or salt thereof |
| 10/13/2004 | EP1466910A1 Process for producing 2-cyanoimino-1,3-thiazolidine |
| 10/13/2004 | EP1466909A1 Halogenobenzyl aminopropionic acid derivatives |
| 10/13/2004 | EP1466898A1 Beta-amyloid protein production/secretion inhibitors |
| 10/13/2004 | EP1466891A1 Carboxylic acid derivative |
| 10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1465882A2 Hetrocyclic modulators of nuclear receptors |
| 10/13/2004 | EP1465881A2 Hydrogenation of precursors to thiazolidinedione antihyperglycemics |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465863A1 Potassium channel modulators |
| 10/13/2004 | EP1465862A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| 10/13/2004 | EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 10/13/2004 | EP1465858A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 10/13/2004 | EP1465854A2 Chalcone derivatives and their use to treat diseases |
| 10/13/2004 | EP1465726A1 Process for preparing nonracemic chiral alcohols |
| 10/13/2004 | EP1465623A1 Urea derivatives |
| 10/13/2004 | EP1280797B1 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1169038A4 Cyclic protein tyrosine kinase inhibitors |
| 10/13/2004 | EP0736036B1 Kininogen inhibitors |
| 10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 10/13/2004 | CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 10/13/2004 | CN1537002A Novel theterocyclic analogs of diphenylethylene compounds |